Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Hodgkin's Disease: A Cytokine-Producing Tumor − A Review

Volumen 5, Edición 5, 1994, pp. 473-538
DOI: 10.1615/CritRevOncog.v5.i5.30
Get accessGet access

SINOPSIS

Cytokines and hematopoietic growth factors are actively involved in regulation of proliferation, differentiation, and cellular functions of various cell lineages. Each cytokine exhibits pleiotropic biological functions on different target cells and subfamilies of cytokines often have redundant biological effects on the same target cell. Hodgkin's disease represents one of the most common human lymphoma entities, the molecular pathogenesis of which is not well understood. Hodgkin's disease is characterized by the presence of typical, presumed malignant Hodgkin and Reed-Sternberg cells in a hyperplastic background of normal reactive lymphocytes, plasma cells, histiocytes, neutrophils, eosinophils, and stromal cells. The histopathological presentation and characteristic clinical features of Hodgkin's disease correlate with an unbalanced production of multiple cytokines. Hodgkin and Reed-Sternberg cells express mRNA and proteins of various cytokines, growth factors, and cytokine receptors, implying a predominant role for cytokines in the pathophysiology of Hodgkin's disease as a tumor of cytokine-producing cells.

CITADO POR
  1. Drexler Hans G., Establishment and Culture of Cell Lines, in The Leukemia-Lymphoma Cell Line FactsBook, 2001. Crossref

  2. Aldinucci Donatella, Poletto Dalisa, Nanni Paola, Degan Massimo, Gloghini Annunziata, Di Francia Raffaele, Russo Stefania, Carbone Antonino, Pinto Antonio, Gattei Valter, Hodgkin and Reed-Sternberg cells express functional c-kit receptors and interact with primary fibroblasts from Hodgkin's disease-involved lymph nodes through soluble and membrane-bound stem cell factor, British Journal of Haematology, 118, 4, 2002. Crossref

  3. Herbst Hermann, Samol Jens, Foss Hans-Dieter, Raff Thorsten, Niedobitek Gerald, Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus, The Journal of Pathology, 182, 3, 1997. Crossref

  4. Wihlborg Christel, Sjöberg Jan, Intaglietta Monica, Axdorph Ulla, Pisa Eva K., Pisa Pavel, Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia, British Journal of Haematology, 104, 2, 1999. Crossref

  5. Mellgren Karin, Hedegaard Chris Juul, Schmiegelow Kjeld, Müller Klaus, Plasma Cytokine Profiles at Diagnosis in Pediatric Patients With Non-Hodgkin Lymphoma, Journal of Pediatric Hematology/Oncology, 34, 4, 2012. Crossref

  6. Gruss Hans-Jürgen, Ulrich Dawn, Braddy Steve, Armitage Richard J., Dower Steven K., Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells, European Journal of Immunology, 25, 7, 1995. Crossref

  7. Pinto Antonio, Gattei Valter, Zagonel Vittorina, Aldinucci Donatella, Degan Massimo, De Iuliis Angela, Rossi Francesca Maria, Mazzocco Francesca Tassan, Godeas Cristiana, Rupolo Maurizio, Poletto Dalisa, Gloghini Annunziata, Carbone Antonino, Gruss Hans-Jürgen, Hodgkin’s disease: A disorder of dysregulated cellular cross-talk, Biotherapy, 10, 4, 1998. Crossref

  8. Miyata Akira, Kojima Kensuke, Yoshino Tadashi, Fujii Soichirou, Shinagawa Katsuji, Ichimura Koichi, Concurrent Hodgkin’s Disease (Mixed Cellularity Type) and T-Cell Chronic Lymphocytic Leukemia/Prolymphocytic Leukemia, International Journal of Hematology, 73, 2, 2001. Crossref

  9. Ma Yue, Visser Lydia, Blokzijl Tjasso, Harms Geert, Atayar Çiǧdem, Poppema Sibrand, van den Berg Anke, The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile, Laboratory Investigation, 88, 5, 2008. Crossref

  10. Isufi Iris, Seetharam Mahesh, Zhou Li, Sohal Davendra, Opalinska Joanna, Pahanish Perry, Verma Amit, Transforming Growth Factor-βSignaling in Normal and Malignant Hematopoiesis, Journal of Interferon & Cytokine Research, 27, 7, 2007. Crossref

  11. Gruss Hans-JÑRgen, Herrmann Friedhelm, Gattei Valter, Gloghini Annunziata, Pinto Antonio, Carbone Antonino, CD40/CD40 Ligand Interactions in Normal, Reactive and Malignant Lympho-Hematopoietic Tissues, Leukemia & Lymphoma, 24, 5-6, 1997. Crossref

  12. Simon Dagmar, Simon Hans-Uwe, Eosinophilic disorders, Journal of Allergy and Clinical Immunology, 119, 6, 2007. Crossref

  13. Nadali Gianpaolo, Vinante Fabrizio, Chilosi Marco, Pizzolo Giovanni, Soluble Molecules as Biological Markers in Hodgkin's Disease, Leukemia & Lymphoma, 26, sup1, 1997. Crossref

  14. Chiarle Roberto, Podda Antonello, Prolla Gabriel, Gong Jerry, Thorbecke G.Jeanette, Inghirami Giorgio, CD30 in Normal and Neoplastic Cells, Clinical Immunology, 90, 2, 1999. Crossref

  15. Al-Hashmi Ibrahim, Decoteau John, Gruss Hans-Jurgen, Zielenska Maria, Thorner Paul, Poon Annette, Reis Marciano, Freedman Melvin, Lorenzana Adonis, Establishment of a Cytokine-Producing Anaplastic Large-Cell Lymphoma Cell Line Containing the t(2;5) Translocation: Potential Role of Cytokines in Clinical Manifestations, Leukemia & Lymphoma, 40, 5-6, 2001. Crossref

  16. Aldinucci Donatella, Lorenzon Debora, Olivo Karin, Rapanà Barbara, Gattei Valter, Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells, Leukemia & Lymphoma, 45, 9, 2004. Crossref

  17. Teruya-Feldstein Julie, Tosato Giovanna, Jaffe Elaine S., The Role of Chemokines in Hodgkin's Disease, Leukemia & Lymphoma, 38, 3-4, 2000. Crossref

  18. Eltoum Isam A., Moore R. Jemison, Cook William, Crowe D. Ralph, Rodgers William H., Siegal Gene P., Epithelioid variant of malignant peripheral nerve sheath tumor (malignant schwannoma) of the urinary bladder, Annals of Diagnostic Pathology, 3, 5, 1999. Crossref

  19. Gruss Hans-Jürgen, Herrmann Friedhelm, CD30 Ligand, a Member of the TNF Ligand Superfamily, with Growth and Activation Control for CD30+ Lymphoid and Lymphoma Cells*, Leukemia & Lymphoma, 20, 5-6, 1996. Crossref

  20. Thomson Jacquelyn A., Seymour John F., Wolf Max, Hodgkin's Disease Complicated by the Nephrotic syndrome in a Man with Kugelberg-Welander Disease, Leukemia & Lymphoma, 42, 3, 2001. Crossref

  21. Lalani Tahaniyat, Simmons Raymond K., Ahmed A. Razzaque, Biology of IL-5 in health and disease, Annals of Allergy, Asthma & Immunology, 82, 4, 1999. Crossref

  22. Leoncini Lorenzo, Spina Donatella, Megha Tiziana, Gallorini Marcella, Tosi Piero, Hummel Michael, Stein Harald, Pileri Stefano, Kraft Rainer, Laissue Jean A., Cottier Hans, Cell Kinetics, Morphology, and MolecularIgVHGene Rearrangements in Hodgkin's Disease, Leukemia & Lymphoma, 26, 3-4, 1997. Crossref

  23. Barry Todd S., Jaffe Elaine S., Sorbara Lynn, Raffeld Mark, Pittaluga Stefania, Peripheral T-Cell Lymphomas Expressing CD30 and CD15, The American Journal of Surgical Pathology, 27, 12, 2003. Crossref

  24. Fiumara Paolo, Snell Virginia, Li Yang, Mukhopadhyay Asok, Younes Mamoun, Gillenwater Ann Marie, Cabanillas Fernando, Aggarwal Bharat B., Younes Anas, Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines, Blood, 98, 9, 2001. Crossref

  25. Clodi Katharina, Asgari Zahra, Younes Mamoun, Palmer J. Lynn, Cabanillas Fernando, Carbone Antonino, Andreeff Michael, Younes Anas, Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease, Cancer, 94, 1, 2002. Crossref

  26. Izban Keith F, Ergin Melek, Huang Qin, Qin Jian-zhong, Martinez Robert L, Schnitzer Bertram, Ni Hongyu, Nickoloff Brian J, Alkan Serhan, Characterization of NF-κB Expression in Hodgkin’s Disease: Inhibition of Constitutively Expressed NF-κB Results in Spontaneous Caspase-Independent Apoptosis in Hodgkin and Reed-Sternberg Cells, Modern Pathology, 14, 4, 2001. Crossref

  27. Izban Keith F, Ergin Melek, Martinez Robert L, Alkan Serhan, Expression of the Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells, Modern Pathology, 13, 12, 2000. Crossref

  28. Teruya-Feldstein Julie, Jaffe Elaine S., Burd Parris R., Kingma Douglas W., Setsuda Joyce E., Tosato Giovanna, Differential Chemokine Expression in Tissues Involved by Hodgkin’s Disease: Direct Correlation of Eotaxin Expression and Tissue Eosinophilia, Blood, 93, 8, 1999. Crossref

  29. Teruya-Feldstein Julie, Jaffe Elaine S., Burd Parris R., Kingma Douglas W., Setsuda Joyce E., Tosato Giovanna, Differential Chemokine Expression in Tissues Involved by Hodgkin’s Disease: Direct Correlation of Eotaxin Expression and Tissue Eosinophilia, Blood, 93, 8, 1999. Crossref

  30. Montaner Silvia, Sodhi Akrit, Servitja Joan-Marc, Ramsdell Amanda K., Barac Ana, Sawai Earl T., Gutkind J. Silvio, The small GTPase Rac1 links the Kaposi sarcoma–associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia, Blood, 104, 9, 2004. Crossref

  31. Gruss Hans-Jürgen., Dower Steven. K., CD30 Ligand: Cloning, Characterisation and Biological Activities, in Etiology of Hodgkin’s Disease, 1995. Crossref

  32. Höpken Uta E., Foss Hans-Dieter, Meyer Dagmar, Hinz Michael, Leder Korinna, Stein Harald, Lipp Martin, Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs, Blood, 99, 4, 2002. Crossref

  33. Gattei Valter, Degan Massimo, Gloghini Annunziata, De Iuliis Angela, Improta Salvatore, Rossi Francesca Maria, Aldinucci Donatella, Perin Vilma, Serraino Diego, Babare Roberta, Zagonel Vittorina, Gruss Hans-Jürgen, Carbone Antonino, Pinto Antonio, CD30 Ligand Is Frequently Expressed in Human Hematopoietic Malignancies of Myeloid and Lymphoid Origin, Blood, 89, 6, 1997. Crossref

  34. Teofili Luciana, Di Febo Anna Laura, Pierconti Francesco, Maggiano Nicola, Bendandi Maurizio, Rutella Sergio, Cingolani Antonella, Di Renzo Nicola, Musto Pellegrino, Pileri Stefano, Leone Giuseppe, Larocca Luigi Maria, Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease, Blood, 97, 4, 2001. Crossref

  35. Pinto A., Aldinucci D., Gloghini A., Zagonel A., Degan M., Perin V., Todesco M., De Iuliis A., Improta S., Sacco C., Gattei V., Gruss H.-J., Carbone A., The role of eosinophils in the pathobiology of Hodgkin's disease, Annals of Oncology, 8, 1997. Crossref

  36. Gruss H.-J., Duyster J., Herrmann F., Structural and biological features of the TNF receptor and TNF ligand superfamilies: Interactive signals in the pathobiology of Hodgkin's disease, Annals of Oncology, 7, 1996. Crossref

  37. Maggio E., van den Berg A., Diepstra A., Kluiver J., Visser L., Poppema S., Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues, Annals of Oncology, 13, 2002. Crossref

  38. Spina Donatella, Leoncini Lorenzo, Close Pauline, Megha Tiziana, Pacenti Lorenzo, Tosi Piero, Pileri Stefano, Sabattini Elena, Kraft Rainer, Laissue Jean A., Cottier Hans, Growth vs. DNA strand breaks in Hodgkin's disease: Impaired proliferative ability of Hodgkin and Reed‐Sternberg cells , International Journal of Cancer, 66, 2, 1996. Crossref

  39. Gupta Jyoti, McCarthy Keith P., An overview of childhood lymphomas, in Progress in Pathology, 2007. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain